D.E. Shaw & Co’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

D.E. Shaw & Co’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-72,165	Closed	-$398K	–	4853
2014 Q1	$398K	Buy	72,165 +46,730	+184%	+$235K	﹤0.01%	3762
2013 Q4	$113K	Sell	25,435 -44,541	-64%	-$151K	﹤0.01%	4360
2013 Q3	$211K	Buy	69,976 +34,507	+97%	+$99.1K	﹤0.01%	4065
2013 Q2	$82K	Buy	+35,469	New	+$71.7K	﹤0.01%	3889

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

D.E. Shaw & Co's CHTP Position: Q2 2014 in Review

D.E. Shaw & Co sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 72,165 shares — an estimated $398K sold.

D.E. Shaw & Co first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $398K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

D.E. Shaw & Co reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
D.E. Shaw & Co sold 72,165 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $398K.
D.E. Shaw & Co first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
D.E. Shaw & Co's CHELSEA THERAPEUTICS INT'L LTD position peaked at $398K in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on D.E. Shaw & Co's 13F filing for Q2 2014, filed 14 Aug 2014.